Synageva BioPharma™ Reports Third Quarter 2013 Financial Results

LEXINGTON, Mass.–(BUSINESS WIRE)–Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, today reported third quarter 2013 financial results and provided other business updates. Synageva announces the hiring of Gregory A. Grabowski, M.D., FACMG Gregory A. Grabowski, M.D. joins Synageva as a distinguished physician and accomplished researcher in the field of rare, genetic diseases. In his role at Synageva, Dr. Grabowski


Business Wire News with Multimedia

Añadir un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.